The National Institutes of Health (NIH), in collaboration with the US Centers for Disease Control and Prevention (CDC), held a three-day consultation workshop to review and finalize Pakistan’s first National Bio-Risk Management Guidelines for Laboratories.
NIH, CDC review national bio-risk management guidelines
ISLAMABAD, Oct 05 (APP): The National Institutes of Health (NIH), in collaboration with the US Centers for Disease Control and Prevention (CDC), held a three-day consultation workshop to review and finalize Pakistan’s first National Bio-Risk Management Guidelines for Laboratories.
The workshop brought together relevant laboratory stakeholders to review the draft guidelines, provide technical input and strengthen the framework for safe, secure and responsible laboratory practices across the country.
Participants discussed measures to strengthen laboratory bio-risk management, biosafety and biosecurity and promote standardized practices across different laboratory settings.
The consultation is aimed at establishing a comprehensive national framework to help laboratories identify, assess and manage biological risks while ensuring safe handling of biological materials.
The initiative also supports efforts to strengthen Pakistan’s public health laboratory system and enhance preparedness for biological threats and their mitigation.
The NIH and CDC reaffirmed their commitment to continued technical collaboration and engagement to strengthen laboratory safety, biosecurity and public health preparedness in Pakistan.
